Two Sigma Advisers’s Chimerix, Inc. CMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,900
| Closed | -$41.4K | – | 2622 |
|
|
2024
Q4 | $41.4K | Sell |
11,900
-20,600
| -63% | -$29.1K | ﹤0.01% | 2294 |
|
|
2024
Q3 | $30.2K | Sell |
32,500
-300
| -0.9% | -$268 | ﹤0.01% | 2237 |
|
|
2024
Q2 | $28.7K | Buy |
32,800
+5,800
| +21% | +$5.5K | ﹤0.01% | 2389 |
|
|
2024
Q1 | $28.6K | Buy |
27,000
+4,700
| +21% | +$4.89K | ﹤0.01% | 2383 |
|
|
2023
Q4 | $21.5K | Buy |
+22,300
| New | +$21.6K | ﹤0.01% | 2446 |
|
|
2023
Q2 | – | Sell |
-43,300
| Closed | -$54.6K | – | 2711 |
|
|
2023
Q1 | $54.6K | Sell |
43,300
-426,300
| -91% | -$696K | ﹤0.01% | 2443 |
|
|
2022
Q4 | $873K | Buy |
469,600
+156,000
| +50% | +$305K | ﹤0.01% | 1634 |
|
|
2022
Q3 | $605K | Buy |
+313,600
| New | +$704K | ﹤0.01% | 1763 |
|
|
2022
Q2 | – | Sell |
-52,400
| Closed | -$240K | – | 2923 |
|
|
2022
Q1 | $240K | Sell |
52,400
-333,900
| -86% | -$1.86M | ﹤0.01% | 2323 |
|
|
2021
Q4 | $2.48M | Sell |
386,300
-574,800
| -60% | -$3.45M | 0.01% | 1085 |
|
|
2021
Q3 | $5.95M | Sell |
961,100
-11,000
| -1% | -$75.6K | 0.02% | 707 |
|
|
2021
Q2 | $7.78M | Buy |
972,100
+240,100
| +33% | +$2M | 0.02% | 659 |
|
|
2021
Q1 | $7.06M | Sell |
732,000
-7,500
| -1% | -$68.8K | 0.02% | 714 |
|
|
2020
Q4 | $3.57M | Sell |
739,500
-63,700
| -8% | -$231K | 0.01% | 962 |
|
|
2020
Q3 | $2M | Buy |
803,200
+3,700
| +0.5% | +$10.9K | 0.01% | 1168 |
|
|
2020
Q2 | $2.48M | Buy |
799,500
+117,400
| +17% | +$304K | 0.01% | 1103 |
|
|
2020
Q1 | $982K | Sell |
682,100
-96,900
| -12% | -$170K | ﹤0.01% | 1500 |
|
|
2019
Q4 | $1.58M | Buy |
779,000
+377,500
| +94% | +$696K | ﹤0.01% | 1344 |
|
|
2019
Q3 | $944K | Buy |
401,500
+160,100
| +66% | +$462K | ﹤0.01% | 1467 |
|
|
2019
Q2 | $1.04M | Buy |
241,400
+13,300
| +6% | +$40.9K | ﹤0.01% | 1494 |
|
|
2019
Q1 | $479K | Buy |
228,100
+93,300
| +69% | +$213K | ﹤0.01% | 1815 |
|
|
2018
Q4 | $346K | Buy |
134,800
+20,700
| +18% | +$69.3K | ﹤0.01% | 1920 |
|
|
2018
Q3 | $444K | Sell |
114,100
-28,200
| -20% | -$120K | ﹤0.01% | 1841 |
|
|
2018
Q2 | $677K | Sell |
142,300
-29,400
| -17% | -$141K | ﹤0.01% | 1791 |
|
|
2018
Q1 | $893K | Sell |
171,700
-2,012
| -1% | -$10.2K | ﹤0.01% | 1595 |
|
|
2017
Q4 | $804K | Buy |
173,712
+98,612
| +131% | +$469K | ﹤0.01% | 1599 |
|
|
2017
Q3 | $394K | Sell |
75,100
-4,900
| -6% | -$24.1K | ﹤0.01% | 1829 |
|
|
2017
Q2 | $436K | Buy |
80,000
+25,900
| +48% | +$136K | ﹤0.01% | 1839 |
|
|
2017
Q1 | $345K | Sell |
54,100
-6,800
| -11% | -$38.6K | ﹤0.01% | 2046 |
|
|
2016
Q4 | $280K | Buy |
+60,900
| New | +$288K | ﹤0.01% | 2096 |
|
|
2016
Q3 | – | Sell |
-91,500
| Closed | -$360K | – | 2340 |
|
|
2016
Q2 | $360K | Buy |
91,500
+64,500
| +239% | +$319K | ﹤0.01% | 1646 |
|
|
2016
Q1 | $138K | Sell |
27,000
-44,700
| -62% | -$292K | ﹤0.01% | 1895 |
|
|
2015
Q4 | $642K | Buy |
+71,700
| New | +$2.58M | ﹤0.01% | 1233 |
|
|
2014
Q3 | – | Sell |
-18,600
| Closed | -$408K | – | 2726 |
|
|
2014
Q2 | $408K | Sell |
18,600
-25,400
| -58% | -$504K | ﹤0.01% | 1810 |
|
|
2014
Q1 | $1M | Buy |
+44,000
| New | +$888K | 0.01% | 1153 |
|
Other funds holding CMRX
BCM
MF
DM
KC
GCL
AAM
FTCM
Two Sigma Advisers's CMRX Position: Q1 2025 in Review
Two Sigma Advisers sold out of Chimerix, Inc. (CMRX) in Q1 2025, closing a stake of 11,900 shares — an estimated $41.4K sold.
Two Sigma Advisers first reported a position in CMRX in Q1 2014 and held it in 35 quarters. The position peaked at $7.78M in Q2 2021. 119 funds tracked by Wall St. Rank hold CMRX as of Q1 2025.
- Two Sigma Advisers reported no remaining Chimerix, Inc. position as of Q1 2025 after selling out during the quarter.
- Two Sigma Advisers sold 11,900 Chimerix, Inc. shares in Q1 2025, an estimated $41.4K.
- Two Sigma Advisers first reported a position in Chimerix, Inc. in Q1 2014 and held it in 35 quarters.
- Two Sigma Advisers's Chimerix, Inc. position peaked at $7.78M in Q2 2021.
- 119 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2025.
Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.